Memantine

Memantine hydrochloride is a raw material. It should be prescribed by experienced doctors in the diagnosis and treatment of Alzheimer's dementia and guided by patients. Treatment can only begin when there are caregivers around the patient who regularly supervise the patient's medication. Dementia should be diagnosed in accordance with current diagnostic criteria and guidelines.

Memantine is a medication used to treat moderate-to-severe Alzheimer's disease. It is less preferred than acetylcholinesterase inhibitors such as donepezil. Treatment should only be continued if beneficial effects are seen. It is taken by mouth.
Memantine was approved for medical use in the United States in 2003. It is available as a generic medication. In 2017, it was the 149th most commonly prescribed medication in the United States, with more than four million prescriptions

Memantine is clinically used for the treatment of moderate to severe senile dementia and parkinsonism syndrome. It is a new type of anti-senile dementia drug and can be used for the treatment of moderate to severe senile dementia.

Memantine is used to treat moderate-to-severe Alzheimer's disease, especially for people who are intolerant of or have a contraindication to AChE (acetylcholinesterase) inhibitors.One guideline recommends memantine or an AChE inhibitor be considered in people in the early-to-mid stage of dementia.

Memantine has been associated with a modest improvement; with small positive effects on cognition, mood, behavior, and the ability to perform daily activities in moderate-to-severe Alzheimer's disease. There does not appear to be any benefit in mild disease.

Memantine when added to donepezil in those with moderate-to-severe dementia resulted in "limited improvements" in a 2017 review. The UK National Institute of Clinical Excellence (NICE) issued guidance in 2018 recommending consideration of the combination of memantine with donepezil in those with moderate-to-severe dementia. Effects in autism are unclear. Recent scientific journal reports are showing guarded promise with severe obsessive compulsive disorder.

Бездә югары сыйфатлы продуктлар һәм көндәшлек бәяләре белән тәэмин итә алырлык бик югары сыйфатлы заводлар бар. Без шулай ук ​​күпләп сатып алу өчен ташламалар бирә алабыз. Manyәм без күп профессиональ йөк экспедицион компанияләре белән хезмәттәшлек итәбез, продуктларны куркынычсыз һәм уңайлы итеп сезнең кулыгызга китерә алабыз. Түләү расланганнан соң якынча 3-20 көн.

Memantine is a medication used to treat moderate-to-severe Alzheimer's disease. It is less preferred than acetylcholinesterase inhibitors such as donepezil. Treatment should only be continued if beneficial effects are seen. It is taken by mouth.
Memantine was approved for medical use in the United States in 2003. It is available as a generic medication. In 2017, it was the 149th most commonly prescribed medication in the United States, with more than four million prescriptions

Memantine HCl is the HCl form of Memantine. Memantine is a well- known neuroprotective drug used for the treatment of Alzheimer's disease. It is believed to be the first neuroprotective drug that has achieve clinical approval by US FDA as well as European.
The development of Alzheimer's disease involves the misfolded mutant proteins such as β-amyloid peptide (Aβ, particularly Aβ1−42). These misfolded mutant protein can increase the NMDA response and further cause severe excitotoxicity.
Memantine suppresses this process through acting as the antagonist of the N-methyl-d- aspartate-sensitive glutamate receptor (NMDARs).
Memantine is also under investigation as a potential treatment for other kind of neurodegenerative disorders such as HIV-associated dementia, neuropathic pain, glaucoma, depression, Huntington's disease, ALS and movement disorders, among other. 

1. Сез завод яки сәүдә компаниясе?
Без индустрияне һәм сәүдәне берләштерүче, бер тәрәзә хезмәтен күрсәтүче компнай. OEM кабул ителергә мөмкин.

2. Сез үрнәкләр бирәсезме? Бушлаймы, әллә өстәмәме?
Бушлай үрнәкләр. Ampleрнәкнең йөк бәясе сезнең ягыгыз белән түләргә тиеш.

3. Сездә сыйфат контроле белән бәйле сертификатлар бармы?
Сыйфатны тәэмин итү өчен ISO 9001: 2008 сертификаты.

4. otитата алу өчен мин нәрсә бирергә тиеш?
Pls безгә кирәк булган продукт төре турында хәбәр итегез, саны, адресы һәм конкрет таләпләр. Котировкалар вакытында белешмә өчен ясалачак.

5. Сез нинди түләү ысулын өстен күрәсез? Нинди терминнар кабул ителә?
Кабул итү шартлары: FOB, CFR, CIF, EXW;
Кабул ителгән түләү валютасы: АКШ доллары;
Кабул ителгән түләү төре: Т / Т, Western Union; Paypal, сәүдә ышандыруы.
Сөйләшкән тел: Инглиз.